+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887787
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Anxiolytics Market size was estimated at USD 1.24 billion in 2023, USD 1.32 billion in 2024, and is expected to grow at a CAGR of 7.27% to reach USD 2.03 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anxiolytics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anxiolytics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Antidepressants
    • Antihistamines
    • Azapirones
    • Benzodiazepines
    • Beta-blockers
    • Nonbenzodiazepines
    • Sedative-hypnotics
  • Form
    • Capsules
    • Tablets
  • Route of Administration
    • Oral
    • Parenteral
  • Indication
    • Generalized Anxiety Disorder
    • Panic Disorder
    • Phobias
    • Posttraumatic Stress Disorder (PTSD)
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Anxiolytics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anxiolytics Market?
  3. What are the technology trends and regulatory frameworks in the Anxiolytics Market?
  4. What is the market share of the leading vendors in the Anxiolytics Market?
  5. Which modes and strategic moves are suitable for entering the Anxiolytics Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Anxiolytics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
5.1.2. Restraints
5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
5.1.3. Opportunities
5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
5.1.4. Challenges
5.1.4.1. Problems related to social-stigma associated with mental disorders
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Anxiolytics Market, by Type
6.1. Introduction
6.2. Antidepressants
6.3. Antihistamines
6.4. Azapirones
6.5. Benzodiazepines
6.6. Beta-blockers
6.7. Nonbenzodiazepines
6.8. Sedative-hypnotics
7. Anxiolytics Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Tablets
8. Anxiolytics Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
9. Anxiolytics Market, by Indication
9.1. Introduction
9.2. Generalized Anxiety Disorder
9.3. Panic Disorder
9.4. Phobias
9.5. Posttraumatic Stress Disorder (PTSD)
10. Anxiolytics Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Americas Anxiolytics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Anxiolytics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Anxiolytics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. AbbVie Inc.
15.1.2. Accord Healthcare US
15.1.3. Akorn Operating Company LLC
15.1.4. Alvogen
15.1.5. Amneal Pharmaceuticals LLC
15.1.6. Apotex Inc.
15.1.7. AstraZeneca PLC
15.1.8. Bausch Health Companies Inc.
15.1.9. Dellwich Healthcare LLP
15.1.10. Eli Lilly and Company
15.1.11. F. Hoffmann-La Roche Ltd.
15.1.12. GlaxoSmithKline PLC
15.1.13. H. Lundbeck A/S
15.1.14. Hameln Pharma GmbH
15.1.15. Hikma Pharmaceuticals PLC
15.1.16. Johnson & Johnson Services, Inc.
15.1.17. Lifecare Neuro Products Limited
15.1.18. Lifegenix
15.1.19. Neurocon Inc.
15.1.20. Noreva Biotech
15.1.21. Novartis AG
15.1.22. Pfizer Inc.
15.1.23. Sanofi S.A.
15.1.24. Sun Pharmaceutical Industries Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANXIOLYTICS MARKET DYNAMICS
FIGURE 7. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Accord Healthcare US
  • Akorn Operating Company LLC
  • Alvogen
  • Amneal Pharmaceuticals LLC
  • Apotex Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Dellwich Healthcare LLP
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Hameln Pharma GmbH
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Lifecare Neuro Products Limited
  • Lifegenix
  • Neurocon Inc.
  • Noreva Biotech
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information